Cargando…

Correction: PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine

Detalles Bibliográficos
Autores principales:	Guo, Song, Ernstsen, Charlotte, Hay-Schmidt, Anders, Kristensen, David Møbjerg, Ashina, Messoud, Olesen, Jes, Christensen, Sarah Louise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278286/ https://www.ncbi.nlm.nih.gov/pubmed/37331969 http://dx.doi.org/10.1186/s10194-023-01606-0

Ejemplares similares

PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine
por: Guo, Song, et al.
Publicado: (2022)

Targeting enkephalins and pituitary adenylate cyclase-activating polypeptide (PACAP) in migraine
por: Ashina, Messoud
Publicado: (2022)

Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP
por: Schytz, Henrik Winther, et al.
Publicado: (2010)

Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis
por: Christensen, Casper Emil, et al.
Publicado: (2022)

Glibenclamide Posttreatment Does Not Inhibit Levcromakalim Induced Headache in Healthy Participants: A Randomized Clinical Trial
por: Kokoti, Lili, et al.
Publicado: (2023)

PACAP38 in human models of primary headaches
por: Ashina, Håkan, et al.
Publicado: (2017)

A c-Fos activation map in nitroglycerin/levcromakalim-induced models of migraine
por: Wu, Shouyi, et al.
Publicado: (2022)

Cilostazol induced migraine does not respond to sumatriptan in a double blind trial
por: Falkenberg, Katrine, et al.
Publicado: (2018)

Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
por: Ashina, Messoud, et al.
Publicado: (2018)

Provoked versus spontaneous migraine attacks: pathophysiological similarities and differences
por: Ashina, Håkan, et al.
Publicado: (2022)

Levcromakalim provokes an acute rapid-onset migraine-like phenotype without inducing cortical spreading depolarization
por: Alpay, Berkay, et al.
Publicado: (2023)

Nitric oxide synthase, Calcitonin Gene-Related Peptide and inflammatory mechanisms are involved in GTN induced neuronal activation
por: Ramachandran, R, et al.
Publicado: (2013)

CGRP in migraine
por: Tfelt-Hansen, Peer, et al.
Publicado: (2009)

The K(ATP) channel in migraine pathophysiology: a novel therapeutic target for migraine
por: Al-Karagholi, Mohammad Al-Mahdi, et al.
Publicado: (2017)

PACAP-38 and PACAP(6–38) Degranulate Rat Meningeal Mast Cells via the Orphan MrgB(3)-Receptor
por: Pedersen, Sara Hougaard, et al.
Publicado: (2019)

The changing faces of migraine
por: Martelletti, Paolo, et al.
Publicado: (2019)

A unique inbred rat strain with sustained cephalic hypersensitivity as a model of chronic migraine-like pain
por: Munro, Gordon, et al.
Publicado: (2018)

Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)
por: Martelletti, Paolo, et al.
Publicado: (2019)

Imaging the inflammatory phenotype in migraine
por: Christensen, Rune Häckert, et al.
Publicado: (2022)

Involvement of adenosine signaling pathway in migraine pathophysiology: a systematic review of preclinical studies
por: Thuraiaiyah, Janu, et al.
Publicado: (2022)

MicroRNA Expression Profiling in Hydatidiform Mole for the Prediction of Postmolar GTN: MicroRNA Profile in Postmolar GTN
por: Teerapakpinyo, Chinachote, et al.
Publicado: (2022)

The pharmacological effect of BGC20-1531, a novel prostanoid EP(4) receptor antagonist, in the Prostaglandin E(2) human model of headache
por: Antonova, Maria, et al.
Publicado: (2011)

Therapeutic novelties in migraine: new drugs, new hope?
por: Do, Thien Phu, et al.
Publicado: (2019)

Migraine aura‐like episodes following sclerotherapy for varicose veins of the lower extremities—A systematic review
por: Bahtiri, Lionesa, et al.
Publicado: (2023)

The chronobiology of migraine: a systematic review
por: Poulsen, Amanda Holmen, et al.
Publicado: (2021)

Volume of the rectus capitis posterior minor muscle in migraine patients: a cross-sectional structural MRI study
por: Hvedstrup, Jeppe, et al.
Publicado: (2020)

Correction to: Therapeutic novelties in migraine: new drugs, new hope?
por: Do, Thien Phu, et al.
Publicado: (2019)

The ATP sensitive potassium channel (K(ATP)) is a novel target for migraine drug development
por: Clement, Amalie, et al.
Publicado: (2023)

Shared and independent roles of CGRP and PACAP in migraine pathophysiology
por: Kuburas, Adisa, et al.
Publicado: (2023)

Migraine induction with calcitonin gene-related peptide in patients from erenumab trials
por: Christensen, Casper Emil, et al.
Publicado: (2018)

Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study
por: Deligianni, Christina, et al.
Publicado: (2023)

Effect of CGRP and sumatriptan on the BOLD response in visual cortex
por: Asghar, Mohammad S., et al.
Publicado: (2012)

GTn Repeat Microsatellite Instability in Uterine Fibroids
por: Kénémé, Bineta, et al.
Publicado: (2019)

The Registry for Migraine (REFORM) study: methodology, demographics, and baseline clinical characteristics
por: Karlsson, William Kristian, et al.
Publicado: (2023)

Brain barriers and their potential role in migraine pathophysiology
por: Wiggers, Astrid, et al.
Publicado: (2022)

Calcitonin gene-related peptide causes migraine aura
por: Al-Khazali, Haidar M., et al.
Publicado: (2023)

Future possibilities in migraine genetics
por: Rudkjobing, Laura Aviaja, et al.
Publicado: (2012)

Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence
por: Raffaelli, Bianca, et al.
Publicado: (2023)

Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency
por: Eigenbrodt, Anna K., et al.
Publicado: (2022)

The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study
por: Rasmussen, Nadja Bredo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e6atus94132a47k2rq8b2uldub